AKT1 and lung carcinoma: PI3K/AKT signaling pathway is becoming a treatment target for many kinds of cancer, including nasopharyngeal carcinoma, pancreatic cancer, thyroid cancer, lung cancer, gastric cancer, bladder cancer and breast cancer [24, 25].